With treatments becoming more complex, the life sciences industry needs more professionals with specialized knowledge.
Dan Rizzo
Advertisement
Articles by Dan Rizzo
What the industry has learned navigating the pandemic and what the future holds for field teams.
Advertisement
Latest Updated Articles
Why Medical Engagement With Key Opinion Leaders Drives Treatment Adoption: Q&A with Dan Rizzo, global head of Veeva business consultingPublished: September 19th 2023 | Updated:
- How Digital Will Redefine the Role of the Rep in 2021—and Beyond
Published: December 4th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
